Status:
COMPLETED
A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
Ramathibodi Hospital
Conditions:
Rectum Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Due to colorectal cancer is the fourth most common malignancy in the world. Some patients had present locally advance stage and need to preoperative concurrent chemoradiation (CCRT) before radical sur...
Detailed Description
After permission was obtained from our institutional review board, a cohort of patients who were diagnosed with rectal cancer and received chemoradiation between January 2011 to December 2017 at Ramat...
Eligibility Criteria
Inclusion
- rectal cancer and received preoperative chemoradiation
Exclusion
- distant organ metastasis
- previous colorectal surgery
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2020
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04443985
Start Date
June 1 2020
End Date
August 10 2020
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chairat Supsamutchai
Bangkok, Bankok, Thailand, 10400